Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases
Cardiovascular diseases (CVDs) have emerged as one of the leading causes of global mortality and health burden, with their prevalence and mortality rates demonstrating a persistent upward trend, thereby posing significant challenges to public health worldwide. Tanshinone IIA (Tan IIA), the principal...
Saved in:
Main Authors: | Lanxiang Du, Chengyan Guan, Hao Zhang, Haoyue Jia, Qiang Wan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1620152/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tanshinone IIA attenuates hepatic stellate cell activation, oxidative stress, and liver fibrosis by inhibiting YAP signaling
by: Dan Wang, et al.
Published: (2025-06-01) -
Therapeutic Potential of Tanshinones in Osteolytic Diseases: From Molecular and Cellular Pathways to Preclinical Models
by: Rafael Scaf de Molon
Published: (2025-07-01) -
Tanshinone IIA alleviates liver fibrosis by suppressing hepatic stellate cell proliferation via ERK/cyclin D1/p-Smad3L signaling axis
by: Wenjing Liao, et al.
Published: (2025-05-01) -
In Vitro Effect of Ferruginol, Tanshinone, and Carnosol Analogues on the Proliferation of Three Breast Cancer Cell Lines
by: Miguel A. González-Cardenete, et al.
Published: (2025-06-01) -
DEVELOPMENT, VALIDATION AND APPLICATION OF ANTI-Xa- AND ANTI-IIa-ENOXAPARINE SODIUM ASSAY
by: B. Yu. Margaeva, et al.
Published: (2019-01-01)